主要评价指标：在24周的治疗期间评估评估奥曲肽植入物的有效性、安全性和耐受性。
Main Outcome Measure: to evaluate the efficacy, safety, and tolerability of the octreotide implant during 24 weeks of treatment.
主要评价指标：在24周的治疗期间评估评估奥曲肽植入物的有效性、安全性和耐受性。
Main Outcome Measure: to evaluate the efficacy, safety, and tolerability of the octreotide implant during 24 weeks of treatment.
应用推荐